跳至主要内容
临床试验/IRCT2014061818134N1
IRCT2014061818134N1已完成2 期

Effect of sesamin supplementation on the glycemic indices, lipid profile, serum levels of inflammatory markers, malondialdehyde and adiponectin in type2 diabetic patients.

Vice chancellor for research, Ahvaz Jundishapur University of Medical Sciences0 个研究点目标入组 44 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 60 years(—)
性别
All

入选标准

  • Main inclusion criteria: : having type 2 diabetes; 30 to 60 years old; BMI<30; Not having severe cardiovascular, hepatic, kidney, gastrointestinal, thyroid or inflammatory diseases; Not using insulin or taking corticosteroids, NSAIDS, immunosuppressives, multivitamin-mineral, fiber and omega 3 supplements since 3 weeks prior to the study and during intervention period; No smoking or addiction; No pregnancy or lactation; Not having any weight loose or weight gain regimes; No use of antibiotics. Main exclusion criteria: drug type and dose fluctuation during intervention period; unwilling to continue the study; looking sensitivity or allergy.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Ahvaz Jundishapur University of Medical Sciences

相似试验